$470 Million is the total value of Ghost Tree Capital, LLC's 55 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | $5,760,000 | -10.7% | 400,000 | 0.0% | 1.22% | -35.5% | |
| KURA | KURA ONCOLOGY INC | $4,025,000 | -3.8% | 230,000 | 0.0% | 0.86% | -30.5% | |
| APLS | APELLIS PHARMACEUTICALS INC | $3,289,000 | -19.2% | 185,000 | 0.0% | 0.70% | -41.7% | |
| GNCA | GENOCEA BIOSCIENCES INC | $2,748,000 | -8.9% | 3,525,000 | 0.0% | 0.58% | -34.2% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,976,000 | -28.4% | 450,000 | 0.0% | 0.42% | -48.3% | |
| MOTS | MOTUS GI HLDGS INC | $510,000 | -29.1% | 100,000 | 0.0% | 0.11% | -49.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-04-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.